Literature DB >> 29968386

Clinical issues in cannabis use.

Yvonne Bonomo1,2,3,4, José Diogo S Souza5, Aidan Jackson1, José Alexandre S Crippa5, Nadia Solowij4,6.   

Abstract

Cannabis is the most commonly used illicit substance worldwide and the prevalence of users continues to increase. Over the last 2 decades, the world has seen significant changes regarding cannabis for recreational use as well as application in its use as a therapeutic medicine. This is likely to have influenced the decreasing perception of risks associated with the use of cannabis. Cannabis, however, is not benign and, depending on the pattern of its use, can incur a range of harmful effects, which have implications when prescribing medicinal cannabinoids for individuals. Based on research evidence from recreational use of cannabis as well as the emerging data from trials of medicinal cannabis, we propose some clinical domains that will need specific considerations when prescribing medicinal cannabis.
© 2018 The British Pharmacological Society.

Entities:  

Keywords:  addiction; cannabinoids; evidence-based medicine; prescribing

Mesh:

Substances:

Year:  2018        PMID: 29968386      PMCID: PMC6177702          DOI: 10.1111/bcp.13703

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

Review 1.  Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review.

Authors:  Samantha J Broyd; Hendrika H van Hell; Camilla Beale; Murat Yücel; Nadia Solowij
Journal:  Biol Psychiatry       Date:  2015-12-08       Impact factor: 13.382

Review 2.  Clinical issues in cannabis use.

Authors:  Yvonne Bonomo; José Diogo S Souza; Aidan Jackson; José Alexandre S Crippa; Nadia Solowij
Journal:  Br J Clin Pharmacol       Date:  2018-08-17       Impact factor: 4.335

Review 3.  Adolescent Cannabis Use: What is the Evidence for Functional Brain Alteration?

Authors:  Valentina Lorenzetti; Silvia Alonso-Lana; George J Youssef; Antonio Verdejo-Garcia; Chao Suo; Janna Cousijn; Michael Takagi; Murat Yücel; Nadia Solowij
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

4.  Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

Authors:  Orrin Devinsky; J Helen Cross; Linda Laux; Eric Marsh; Ian Miller; Rima Nabbout; Ingrid E Scheffer; Elizabeth A Thiele; Stephen Wright
Journal:  N Engl J Med       Date:  2017-05-25       Impact factor: 91.245

Review 5.  The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users.

Authors:  Valentina Lorenzetti; Nadia Solowij; Murat Yücel
Journal:  Biol Psychiatry       Date:  2015-12-04       Impact factor: 13.382

Review 6.  Cannabis effects on driving skills.

Authors:  Rebecca L Hartman; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-12-07       Impact factor: 8.327

7.  Young adult sequelae of adolescent cannabis use: an integrative analysis.

Authors:  Edmund Silins; L John Horwood; George C Patton; David M Fergusson; Craig A Olsson; Delyse M Hutchinson; Elizabeth Spry; John W Toumbourou; Louisa Degenhardt; Wendy Swift; Carolyn Coffey; Robert J Tait; Primrose Letcher; Jan Copeland; Richard P Mattick
Journal:  Lancet Psychiatry       Date:  2014-09-10       Impact factor: 27.083

Review 8.  Medical Cannabinoids in Children and Adolescents: A Systematic Review.

Authors:  Shane Shucheng Wong; Timothy E Wilens
Journal:  Pediatrics       Date:  2017-11       Impact factor: 7.124

9.  Transfer of Inhaled Cannabis Into Human Breast Milk.

Authors:  Teresa Baker; Palika Datta; Kathleen Rewers-Felkins; Heather Thompson; Raja R Kallem; Thomas W Hale
Journal:  Obstet Gynecol       Date:  2018-05       Impact factor: 7.661

Review 10.  The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study.

Authors:  Louisa Degenhardt; Alize J Ferrari; Bianca Calabria; Wayne D Hall; Rosana E Norman; John McGrath; Abraham D Flaxman; Rebecca E Engell; Greg D Freedman; Harvey A Whiteford; Theo Vos
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

View more
  6 in total

Review 1.  Clinical issues in cannabis use.

Authors:  Yvonne Bonomo; José Diogo S Souza; Aidan Jackson; José Alexandre S Crippa; Nadia Solowij
Journal:  Br J Clin Pharmacol       Date:  2018-08-17       Impact factor: 4.335

2.  Clinical trial simulations of the interaction between cannabidiol and clobazam and effect on drop-seizure frequency.

Authors:  Kirsten Riber Bergmann; Karen Broekhuizen; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2019-12-12       Impact factor: 4.335

3.  Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations.

Authors:  José Diogo S Souza; Maíra Fassoni-Ribeiro; Rayssa Miranda Batista; Juliana Mayumi Ushirohira; Antonio W Zuardi; Francisco S Guimarães; Alline C Campos; Flávia de Lima Osório; Daniel Elias; Cacilda S Souza; AndRea A Fassoni; Jaime E C Hallak; José Alexandre S Crippa
Journal:  Front Pharmacol       Date:  2022-05-19       Impact factor: 5.988

4.  Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues.

Authors:  Clara M Vecchini Rodríguez; Yma Escalona Meléndez; Jacqueline Flores-Otero
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review.

Authors:  Danielle Hen-Shoval; Aron Weller; Abraham Weizman; Gal Shoval
Journal:  Int J Environ Res Public Health       Date:  2022-01-04       Impact factor: 3.390

6.  Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic.

Authors:  José Diogo S Souza; Antonio W Zuardi; Francisco S Guimarães; Flávia de Lima Osório; Sonia Regina Loureiro; Alline Cristina Campos; Jaime E C Hallak; Rafael G Dos Santos; Isabella Lara Machado Silveira; Karina Pereira-Lima; Julia Cozar Pacheco; Juliana Mayumi Ushirohira; Rafael Rinaldi Ferreira; Karla Cristinne Mancini Costa; Davi Silveira Scomparin; Franciele Franco Scarante; Isabela Pires-Dos-Santos; Raphael Mechoulam; Flávio Kapczinski; Benedito A L Fonseca; Danillo L A Esposito; Maristela Haddad Andraus; José Alexandre S Crippa
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.